A COST-CONSEQUENCE ANALYSIS OF PONATINIB VERSUS IMATINIB IN PATIENTS WITH NEWLY DIAGNOSED PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA IN THE UNITED STATES

被引：0
|
作者：
Hernandez, L. G. [1 ]
Davies, S. [2 ]
Li, C. [3 ]
Reddick, L. E. [1 ]
Jensen, I [2 ]
机构：
[1] Takeda Pharmaceut Amer Inc, Lexington, MA USA
[2] PRECISIONheor, Precis Value & Hlth, Boston, MA USA
[3] Takeda Dev Ctr Amer Inc, Lexington, MA USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE165
引用
收藏
页码：S88 / S88
页数：1
相关论文
共 50 条
  • [21] Clinical effect of imatinib added to intensive combination chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia
    K-H Lee
    J-H Lee
    S-J Choi
    J-H Lee
    M Seol
    Y-S Lee
    W-K Kim
    J-S Lee
    E-J Seo
    S Jang
    C-J Park
    H-S Chi
    Leukemia, 2005, 19 : 1509 - 1516
  • [22] THE LONG-TERM OUTCOME OF ELDERLY PATIENTS WITH PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH plus ALL) IN THE IMATINIB ERA
    Delannoy, A.
    Delabesse, E.
    Lheritier, V.
    Castaigne, S.
    Rigal-Huguet, F.
    Raffoux, E.
    Garban, F.
    Legrand, O.
    Bologna, S.
    Dubruille, V.
    Turlure, P.
    Reman, O.
    Delain, M.
    Isnard, F.
    Coso, D.
    Raby, P.
    Buzyn, A.
    Cailleres, S.
    Darre, S.
    Fohrer, C.
    Sonet, A.
    Bilhou-Nabera, C.
    Bene, M. -C.
    Dombret, H.
    Thomas, X.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 30 - 31
  • [23] Additional chromosomal abnormalities and their prognostic significance in adult Philadelphia-positive acute lymphoblastic leukemia: with or without imatinib in chemotherapy
    Li, Yenan
    Qiu, Lugui
    Zou, Dehui
    Zhao, Yaozhong
    Mi, Yingchang
    Wang, Jianxiang
    ANNALS OF HEMATOLOGY, 2009, 88 (11) : 1069 - 1077
  • [24] Additional chromosomal abnormalities and their prognostic significance in adult Philadelphia-positive acute lymphoblastic leukemia: with or without imatinib in chemotherapy
    Yenan Li
    Lugui Qiu
    Dehui Zou
    Yaozhong Zhao
    Yingchang Mi
    Jianxiang Wang
    Annals of Hematology, 2009, 88 : 1069 - 1077
  • [25] A phase II trial of ponatinib and blinatumomab in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph plus ALL)
    Short, Nicholas James
    Jabbour, Elias
    Jain, Nitin
    Macaron, Walid
    Huang, Xuelin
    Montalban-Bravo, Guillermo
    Kadia, Tapan M.
    Daver, Naval Guastad
    Haddad, Fadi
    Zoghbi, Marianne
    Nasnas, Cedric Christophe
    Nasr, Lewis Fady
    Mayor, Ejiroghene
    Deen, Wuliamatu
    Thankachan, Jennifer
    Loiselle, Christopher
    Garris, Rebecca
    Konopleva, Marina
    Ravandi, Farhad
    Kantarjian, Hagop M.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [26] First report of PhALLCON: A phase 3 study comparing ponatinib (pon) vs imatinib (im) in newly diagnosed patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph plus ALL).
    Jabbour, Elias
    Kantarjian, Hagop M.
    Aldoss, Ibrahim
    Montesinos, Pau
    Leonard, Jessica Taft
    Gomez-Almaguer, David
    Baer, Maria R.
    Gambacorti-Passerini, Carlo
    McCloskey, James
    Minami, Yosuke
    Papayannidis, Cristina
    Geraldo Rocha, Vanderson
    Rousselot, Philippe
    Vachhani, Pankit
    Wang, Eunice S.
    Wang, Bingxia
    Hennessy, Meliessa
    Vorog, Alexander
    Patel, Niti
    Ribera, Josep-Maria
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (36_SUPPL) : 398868 - 398868
  • [27] First report of PhALLCON: A phase 3 study comparing ponatinib (pon) vs imatinib (im) in newly diagnosed patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph plus ALL).
    Jabbour, Elias
    Kantarjian, Hagop M.
    Aldoss, Ibrahim
    Montesinos, Pau
    Leonard, Jessica Taft
    Gomez-Almaguer, David
    Baer, Maria R.
    Gambacorti-Passerini, Carlo
    McCloskey, James
    Minami, Yosuke
    Papayannidis, Cristina
    Rocha, Vanderson Geraldo
    Rousselot, Philippe
    Vachhani, Pankit
    Wang, Eunice S.
    Wang, Bingxia
    Hennessy, Meliessa
    Vorog, Alexander
    Patel, Niti
    Ribera, Josep-Maria
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [28] Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL)
    Wassmann, Barbara
    Pfeifer, Heike
    Goekbuget, Nicola
    Beelen, Dietrich W.
    Beck, Joachim
    Stelljes, Matthias
    Bornhaeuser, Martin
    Reichle, Albrecht
    Perz, Jolanta
    Haas, Rainer
    Ganser, Arnold
    Schmid, Mathias
    Kanz, Lothar
    Lenz, Georg
    Kaufmann, Martin
    Binckebanck, Anja
    Brueck, Patrick
    Reutzel, Regina
    Gschaidmeier, Harald
    Schwartz, Stefan
    Hoelzer, Dieter
    Ottmann, Oliver G.
    BLOOD, 2006, 108 (05) : 1469 - 1477
  • [29] Use of cluster analysis for immunophenotypic pattern identification in philadelphia-positive acute lymphoblastic leukemia in children
    Buldini, B.
    Zangrando, A.
    Tosato, F.
    Michielotto, B.
    Benetello, A.
    Giarin, E.
    Cazzaniga, G.
    Veltroni, M.
    Arico, M.
    Basso, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : S37 - S37
  • [30] Long-term follow-up of imatinib plus combination chemotherapy in patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia
    Lim, Sung-Nam
    Joo, Young-Don
    Lee, Kyoo-Hyung
    Kim, Dae-Young
    Lee, Je-Hwan
    Lee, Jung-Hee
    Chi, Hyun-Sook
    Yun, Sung-Cheol
    Lee, Won Sik
    Lee, Sang Min
    Park, Seonyang
    Kim, Inho
    Sohn, Sang Kyun
    Moon, Joon Ho
    Ryoo, Hun-Mo
    Bae, Sung Hwa
    Hyun, Myung Soo
    Kim, Min Kyoung
    Kim, Hyeoung Joon
    Yang, Deok-Hwan
    Eom, Hyeon-Seok
    Lee, Gyeong-Won
    Jung, Chul Won
    Won, Jong-Ho
    Kim, Hawk
    Lee, Jae-Hoon
    Shin, Ho-Jin
    Jang, Dae-Young
    AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (11) : 1013 - 1020
12345